Found 320 matching trials
Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)
PHASE1This trial is a prospective, multi-center, randomized comparison study of 2...
Location
Multiple Locations
Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)
N/ANonrandomized, prospective, observational, multi-site registry to assess lo...
Location
Multiple Locations
Research In Viral Eradication of HIV Reservoirs
PHASE2This study will be a two-arm prospective 1:1 randomised controlled trial co...
Location
Brighton and Sussex University Hospitals NHS Trust
Pre-Exposure Prophylaxis for Transgender Women in the US and South America
PHASE2A study to assess the feasibility, acceptability, and preliminary impact of...
Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain
PHASE4The purpose of this research study is to understand why certain HIV medicat...
Location
Adult Specialty Care Clinic-East Carolina University
Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)
PHASE4The goal of this clinical study is to learn how safe it is to switch to an ...
Location
Franco Felizarta, MD
Project Engage: Oral PrEP Acceptability
PHASE2This study is a two-arm open label acceptability study that will examine ac...
Location
MatCH Research Unit
Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy
PHASE2HIV infected pregnant women may take single-dose nevirapine (SD NVP) prior ...
Location
Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
PHASE3Randomized, blinded, placebo-controlled trial to demonstrate if pre-exposur...
Location
Moi University - Indiana University
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
PHASE2This study was done with people who were infected with HIV and needed to st...
Location
Alabama Therapeutics CRS (5801)